| Indiana Resources Limited (IDA) ORDINARY FULLY PAID |
Materials |
$12 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Apr 2026 3:03PM |
$0.030 |
$0.018 |
fallen by
40%
|
|
IDA - Price-sensitive ASX Announcement
Full Release
Key Points
- Indiana Resources Limited reported a consolidated closing cash balance of $31.2 million at 31 March 2026.
- The company experienced significant cash outflows of $0.3 million in administrative costs and $0.9 million in legal costs related to arbitration with Loricatus.
- Exploration and evaluation costs for the quarter amounted to $0.7 million.
- No new mining tenements were acquired or disposed of during the quarter.
- A strategic review is underway to unlock value from South Australian assets amid ongoing arbitration regarding settlement proceeds from Tanzania.
- The Appendix 5B report indicates net cash used in operating activities was $(1.6) million for the quarter.
- Payments to directors totaled $74,000 during the quarter.
- The company is focused on advancing its exploration projects in the Central Gawler Craton Province, South Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Constellation Technologies Limited (CT1) ORDINARY FULLY PAID |
Information Technology |
$4 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Apr 2026 3:03PM |
$0.003 |
$0.003 |
fallen by
0%
|
|
CT1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Constellation Technologies Limited is an IoT and Digital Solutions company listed on the ASX under the ticker CT1.
- The company is involved in designing, engineering, building, and integrating systems for various industry verticals.
- During the quarter ending 31 March 2026, the company reported customer receipts of $489k.
- Constellation Technologies received an R&D tax incentive rebate of $287k.
- Net cash from operating activities was $170k for the quarter.
- Cash reserves at the end of the quarter stood at $536k.
- Operational highlights include expansion in the Defence sector, private school sector, healthcare, aged care, and sports and hospitality venues.
- The company is advancing its Food Safety & Compliance platform with new technologies like AI-based menu preparation.
- No new equity or debt was issued during the quarter.
- Related party cash payments for the quarter were $62k.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Merino & Co. Limited (MNC) ORDINARY FULLY PAID |
Consumer Discretionary |
$6 |
Quarterly Appendix 4C Cash Flow Report
|
30 Apr 2026 3:01PM |
$0.090 |
$0.095 |
risen by
5.56%
|
|
MNC - Price-sensitive ASX Announcement
Full Release
Key Points
- Merino & Co. Limited quarterly cash flow report for March 31, 2026.
- Net cash used in operating activities: $389,000 in the quarter.
- Receipts from customers: $442,000.
- Investing activities net inflow: $12,000.
- Net cash used in financing activities: $128,000.
- Cash balance at the end of the quarter: $654,000.
- Payments to related parties: $121,000.
- Company expects operational cash flow improvements.
- No new equity raising during the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tyranna Resources Limited (TYX) ORDINARY FULLY PAID |
Materials |
$12 |
Proposed issue of securities - TYX
|
30 Apr 2026 3:01PM |
$0.003 |
$0.003 |
fallen by
0%
|
|
| Renegade Exploration Limited (RNX) ORDINARY FULLY PAID |
Materials |
$5 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Apr 2026 2:59PM |
$0.003 |
$0.003 |
fallen by
16.67%
|
|
RNX - Price-sensitive ASX Announcement
Full Release
Key Points
- Renegade Exploration Limited (ASX:RNX) is focused on minerals exploration and development in Australia and North America.
- During the quarter ending 31 March 2026, Renegade reported a net cash outflow from operating activities of $152,000.
- The company spent $150,000 on exploration and evaluation, with $138,000 allocated to USA projects and $12,000 to NW Queensland.
- The company increased its loan facility to $1 million and extended its maturity to October 11, 2026, with $450,000 drawn by the quarter's end.
- Renegade executed a binding agreement to divest its ~22% interest in the Carpentaria Joint Venture and ~35% interest in EPM 8588 to True North Copper Limited for $2.88 million.
- Cash at the end of the period totaled $16,000 with an additional $550,000 available from unused facilities.
- Payments totaling $66,000 were made to related parties for director fees and consulting services.
- Renegade's net cash from financing activities during the period was $200,000.
- The company reported an estimated 1.87 quarters of funding available based on current outflows.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Elevra Lithium Limited (ELV) ORDINARY FULLY PAID |
Materials |
$885 |
Change in substantial holding
|
30 Apr 2026 2:57PM |
$13.630 |
$4.560 |
fallen by
66.54%
|
|
| Invictus Energy Ltd (IVZ) ORDINARY FULLY PAID |
Energy |
$111 |
Cleansing Notice
|
30 Apr 2026 2:56PM |
$0.063 |
$0.062 |
fallen by
1.59%
|
|
| Enterprise Metals Limited (ENT) ORDINARY FULLY PAID |
Materials |
$6 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Apr 2026 2:54PM |
$0.004 |
$0.003 |
fallen by
25%
|
|
ENT - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarter ended 31 March 2026 for Enterprise Metals Limited
- Murchison Project shows rare earth potential
- Net cash used in operating activities was $(67,000)
- Net cash used in investing activities was $(313,000)
- Cash balance at the end of the quarter was $435,000
- 110.8 million options exercised, raising $611,000
- Related party payments amounted to $53,000
- Further exploration and shareholder support acknowledged
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Iron Bear Resources Ltd (IBR) ORDINARY FULLY PAID |
Materials |
$24 |
Quarterly Activities Report and Appendix 5B
|
30 Apr 2026 2:54PM |
$0.053 |
$0.022 |
fallen by
58.49%
|
|
IBR - Price-sensitive ASX Announcement
Full Release
Key Points
- Development agreement with Vale S.A. for funding and earning 75% of the Iron Bear Project.
- Production of high-quality DR grade concentrate and low carbon direct reduction pellets.
- Scoping study outlines compelling project economics with significant NPV and IRR.
- Pre-Feasibility Study managed by Hatch to be completed in Q2 2026.
- Significant economic impact in Quebec and Newfoundland and Labrador from the Iron Bear project.
- Iron Bear Project aims to de-risk assets for a decision to mine in three to five years.
- Exploration approvals granted for Phase 1 drilling program in Newfoundland.
- Cash flow details including operational, investing, and financing activities.
- Payments to related parties and their implications detailed in Appendix 5B.
- Active engagement with government entities and presence at trade shows for stakeholder engagement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Critical Resources Limited (CRR) ORDINARY FULLY PAID |
Materials |
$31 |
CRR extends battery technology evaluation program
|
30 Apr 2026 2:52PM |
$0.008 |
$0.009 |
risen by
12.50%
|
|
| Invictus Energy Ltd (IVZ) ORDINARY FULLY PAID |
Energy |
$111 |
Application for quotation of securities - IVZ
|
30 Apr 2026 2:51PM |
$0.063 |
$0.062 |
fallen by
1.59%
|
|
| Tyranna Resources Limited (TYX) ORDINARY FULLY PAID |
Materials |
$12 |
Acquisition of Final 20% interest in Angolan Minerals
|
30 Apr 2026 2:51PM |
$0.003 |
$0.003 |
fallen by
0%
|
|
| Peppermint Innovation Limited (PIL) ORDINARY FULLY PAID |
Information Technology |
$13 |
Application for quotation of securities - PIL
|
30 Apr 2026 2:48PM |
$0.004 |
$0.004 |
fallen by
0%
|
|
| Blackwall Limited (BWF) ORDINARY FULLY PAID |
Financials |
$16 |
Change of Director's Interest Notice
|
30 Apr 2026 2:47PM |
$0.150 |
$0.096 |
fallen by
36%
|
|
| Cadence Opportunities Fund Limited (CDO) ORDINARY FULLY PAID |
Financials |
$40 |
Application for quotation of securities - CDO
|
30 Apr 2026 2:47PM |
$2.130 |
$2.170 |
risen by
1.88%
|
|
| Pacgold Limited (PGO) ORDINARY FULLY PAID |
Materials |
$83 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Apr 2026 2:47PM |
$0.115 |
$0.155 |
risen by
34.78%
|
|
PGO - Price-sensitive ASX Announcement
Full Release
Key Points
- Pacgold Limited's significant progress in the White Dam Gold Operation.
- Completion of commissioning and increase in production capacity at White Dam.
- RC drilling program at Vertigo target contributes to anticipated MRE upgrade.
- Profit share agreement secured for the Wadnaminga Project.
- Pacgold Limited ends the quarter with $6.47 million in cash.
- Transition from explorer to gold producer with initial gold production.
- Net cash decrease due to exploration, evaluation, development, and production expenses.
- Successful exercise of options contributing to cash inflow.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pioneer Minerals Limited (PMM) ORDINARY FULLY PAID |
Materials |
$19 |
Results of Meeting
|
30 Apr 2026 2:47PM |
$0.190 |
$0.255 |
risen by
34.21%
|
|
| ASF Group Limited (AFA) ORDINARY FULLY PAID |
Financials |
$35 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Apr 2026 2:46PM |
$0.057 |
$0.044 |
fallen by
22.81%
|
|
AFA - Price-sensitive ASX Announcement
Full Release
Key Points
- Executed a Debt to Equity Conversion Deed with Rey Resources Pty Ltd.
- Maintained a cash balance of approximately $1.561 million as of 31 March 2026.
- Investments in ActivEX Limited and Key Petroleum Limited.
- ASF Capital exploring digital currency exchange services.
- ASF Technologies developed a patented engine design.
- Quarterly net cash used in operating activities was $(326,000).
- No new financing activities were undertaken during the quarter.
- Payments to related parties included consulting and director fees.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Toro Energy Limited (TOE) ORDINARY FULLY PAID |
Energy |
- |
Results of First Court Hearing
|
30 Apr 2026 2:45PM |
$0.560 |
$0.550 |
fallen by
1.79%
|
|
TOE - Price-sensitive ASX Announcement
Full Release
Key Points
- Toro Energy Ltd is involved in a scheme of arrangement for acquisition by Iso Australia Operations Pty Ltd.
- The Federal Court of Australia approved the convening of a meeting for Toro shareholders to vote on the scheme.
- The Scheme Booklet will be dispatched to shareholders on or around 7 May 2026.
- The Scheme Meeting is scheduled for 9 June 2026.
- The scheme is recommended by Toro's independent board committee, subject to no superior proposal and favorable independent expert report.
- Toro Shareholders are encouraged to read the Scheme Booklet before voting.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ballymore Resources Limited (BMR) ORDINARY FULLY PAID |
Materials |
$31 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Apr 2026 2:44PM |
$0.145 |
$0.123 |
fallen by
15.52%
|
|
BMR - Price-sensitive ASX Announcement
Full Release
Key Points
- Dittmer underground access expansion for Stage 6 resource drilling.
- Visible gold identified in stream sediments, extending Dittmer gold corridor.
- CEI funding of $383k secured for surveys in Dittmer and Ruddygore.
- Quarterly exploration expenditure totaled $1.34 million.
- Cash at the end of the quarter was $1.368 million.
- Ballymore holds interests in multiple granted tenements across Queensland.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| VHM Limited (VHM) ORDINARY FULLY PAID |
Materials |
$75 |
Change of Director's Interest Notice
|
30 Apr 2026 2:43PM |
$0.245 |
$0.240 |
fallen by
2.04%
|
|
| Delta Lithium Limited (DLI) ORDINARY FULLY PAID |
Materials |
$119 |
Change in substantial holding for BM1
|
30 Apr 2026 2:41PM |
$0.230 |
$0.165 |
fallen by
28.26%
|
|
| Ballard Mining Limited (BM1) ORDINARY FULLY PAID |
Materials |
$194 |
Change in substantial holding from DLI
|
30 Apr 2026 2:41PM |
$0.660 |
$0.650 |
fallen by
1.52%
|
|
| Nexalis Therapeutics Ltd (NX1) ORDINARY FULLY PAID |
Health Care |
$4 |
Mar26 Appendix 4C Cash Flow Report
|
30 Apr 2026 2:40PM |
$0.023 |
$0.015 |
fallen by
34.78%
|
|
NX1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Nexalis Therapeutics Limited reported a net cash outflow from operating activities of $474,000 for the quarter ending 31 March 2026.
- The company received $281,000 from borrowings under its funding facility with Linlithgow Family Office.
- The total net cash from financing activities was $565,000 for the quarter.
- Nexalis Therapeutics drew down $281,000 under a facility designed to finance clinical trials, with a noted interest of 15% per annum.
- The company has a total available funding of $50,998,000, with estimated 107.59 quarters of funding available.
- Payments to related parties totaled $19,000, which included salaries to key management personnel.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nexalis Therapeutics Ltd (NX1) ORDINARY FULLY PAID |
Health Care |
$4 |
Mar26 Quarterly Activities Report
|
30 Apr 2026 2:40PM |
$0.023 |
$0.015 |
fallen by
34.78%
|
|
NX1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Nexalis Therapeutics Ltd completed its transition from InhaleRx Limited with a new ASX ticker NX1.
- The March 2026 quarter marked the transition from clinical preparation to active execution for Nexalis.
- Three drug candidates under development: IRX-211 for Breakthrough Cancer Pain, IRX-616a for Panic Disorder, and SRX-25 for Treatment-Resistant Depression.
- IRX-616a Phase 1 trial commenced with first patient dosing for Panic Disorder.
- IRX-211 Phase 2 program progressed in site readiness and patient recruitment for Breakthrough Cancer Pain.
- SRX-25 program advanced with Phase 1 protocol finalization and intellectual property strategy development.
- Company maintains a focus on efficient clinical trial execution and disciplined capital allocation.
- Nexalis aims for US FDA New Drug Approval for each drug candidate.
- No cash payments to Directors during the quarter; entitlements expected to be paid through performance rights.
- Net cash outflow from operating activities was $474k, with significant funding from a placement and funding agreement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
